CD52 expression on plasma cells and its subsets
. | All CD38+ plasma cells . | . | CD38+/CD45+ plasma cells . | . | CD38+/CD45- plasma cells . | . | |||
---|---|---|---|---|---|---|---|---|---|
Diagnosis . | % cells expressing CD52 . | % patients positive* for CD52 . | % cells expressing CD52 . | % patients positive* for CD52 . | % cells expressing CD52 . | % patients positive* for CD52 . | |||
MGUS, n = 9 | 44 (35; 4-65) | 67 | 68 (66; 34-97) | 67 | 18 (23; 3-57) | 33 | |||
Multiple myeloma, n = 23 | 23 (30; 1-92) | 52 | 88 (75; 21-99) | 78 | 6 (18; 0.2-97) | 13 | |||
Amyloid, n = 29 | 15 (19; 3-75) | 34 | 82 (75; 9-99) | 90 | 9 (14; 0.4-67) | 17 |
. | All CD38+ plasma cells . | . | CD38+/CD45+ plasma cells . | . | CD38+/CD45- plasma cells . | . | |||
---|---|---|---|---|---|---|---|---|---|
Diagnosis . | % cells expressing CD52 . | % patients positive* for CD52 . | % cells expressing CD52 . | % patients positive* for CD52 . | % cells expressing CD52 . | % patients positive* for CD52 . | |||
MGUS, n = 9 | 44 (35; 4-65) | 67 | 68 (66; 34-97) | 67 | 18 (23; 3-57) | 33 | |||
Multiple myeloma, n = 23 | 23 (30; 1-92) | 52 | 88 (75; 21-99) | 78 | 6 (18; 0.2-97) | 13 | |||
Amyloid, n = 29 | 15 (19; 3-75) | 34 | 82 (75; 9-99) | 90 | 9 (14; 0.4-67) | 17 |
Values given are median (mean; range)
Positive indicates > 20% cells expressing CD52